Fulcrum Therapeutics Company
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.
Industry:
Loss of Proteostasis
Technology:
Cancer
Headquarters:
United States
Founded Date:
2016
Funding Status:
IPO
Estimated Revenue:
$1B to $10B
Employee Number:
51-100